(NYSE: RMD) Resmed's forecast annual revenue growth rate of 5.87% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.
Resmed's revenue in 2025 is $4,926,773,000.On average, 8 Wall Street analysts forecast RMD's revenue for 2025 to be $750,292,971,791, with the lowest RMD revenue forecast at $749,109,371,347, and the highest RMD revenue forecast at $751,636,069,701. On average, 8 Wall Street analysts forecast RMD's revenue for 2026 to be $804,418,275,471, with the lowest RMD revenue forecast at $796,291,835,496, and the highest RMD revenue forecast at $813,406,236,752.
In 2027, RMD is forecast to generate $858,599,976,045 in revenue, with the lowest revenue forecast at $847,098,975,034 and the highest revenue forecast at $876,679,439,780.